GNRH1 and prostate cancer: The pathways that were significantly enriched in GC-RG compared with those in GC-CG were prostate cancer metabolism, endocrine resistance, GnRH secretion, choline metabolism in cancer, ovarian steroidogenesis, pathways in cancer, and glycerophospholipid metabolism (Figure 3b).